Form 4: NHC President & COO Sells Shares for Tax Obligations

National Healthcare Corp's President & COO, Robert Michael Ussery, disposed of 2,063 common shares to cover tax obligations related to restricted stock vesting.

Summary

• Robert Michael Ussery, President & COO of National Healthcare Corp (NHC), reported a transaction involving company common stock.
• On December 31, 2025, 2,063 shares of common stock were disposed of at a price of $137.09 per share.
• This disposal was a 'tax withholding' transaction (Code F), meaning shares were withheld by the company to satisfy tax obligations upon the vesting of restricted stock.
• A total of 4,835 restricted shares, originally granted on March 8, 2023, March 5, 2024, and March 5, 2025, vested on January 1, 2026.
• Following this transaction, Ussery beneficially owns 158,460 shares of NHC common stock directly.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine tax withholding, indicating the successful vesting of executive compensation. It is not a discretionary sale, and the executive retains a substantial holding.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of previously granted restricted stock, which is a form of executive compensation.
• The executive still holds a significant number of shares (158,460), aligning his interests with shareholders.

Negatives

• A disposal of shares, even for tax purposes, reduces the executive's direct ownership, though it is not a discretionary sale.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine insider transaction report, common across all industries, reflecting executive compensation practices and tax obligations upon restricted stock vesting. It does not provide specific insights into broader healthcare industry trends or competitive positioning.

Comparison to Industry Standards

• The transaction is a standard tax withholding event upon restricted stock vesting, a common practice for executive compensation across publicly traded companies.
• It aligns with typical corporate governance practices for managing equity awards and associated tax liabilities.
• No specific comparable companies or projects are mentioned in this filing.

Stakeholder Impact

• Shareholders: The transaction is a routine tax withholding, not a discretionary sale, which generally has a neutral impact on shareholder perception. The executive's continued significant ownership aligns interests.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where the President & COO disposed of shares to cover tax obligations upon restricted stock vesting. It is not a discretionary sale and does not indicate any change in the company's fundamentals or the executive's confidence. The executive retains a substantial equity stake. Therefore, it provides no new information to warrant a change in investment recommendation, suggesting a 'hold' position based solely on this filing.

Keywords

National Healthcare Corp, NHC, Form 4, Insider Transaction, Stock Sale, Restricted Stock, Tax Withholding, Executive Compensation, Robert Michael Ussery